Risankizumab Demonstrates Superiority to Secukinumab for Plaque Psoriasis

In a phase 3, comparator study in adults with plaque psoriasis, patients taking
risankizumab achieved greater skin clearance than those taking secukinumab...

Source: The Rheumatologist - February 5, 2020 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: DMARDs & Immunosuppressives Drug Updates plaque psoriasis risankizumab secukinumab Source Type: research